Latest News
Conference Coverage
ERAS protocol for cesarean delivery reduces opioid usage
GRAPEVINE, TEX. – An enhanced recovery after surgery (ERAS) pathway for cesarean delivery decreased postoperative opioid usage by 62% in one...
Conference Coverage
Salpingectomy adds little time and no complications to cesarean delivery
GRAPEVINE, TEXAS – A new meta-analysis can inform shared decision-making for those seeking to reduce risk of ovarian...
Latest News
Washington State grapples with coronavirus outbreak
King County, Wash. is Ground Zero for the first outbreak on U.S. soil.
Latest News
Bad behavior by medical trainees target of new proposal
Unprofessional behaviors by medical trainees are universally deemed egregious and worthy of discipline, but often these lapses may offer teachable...
Feature
The fate of the ACA now rests with the U.S. Supreme Court
The U.S. Supreme Court has agreed to hear Texas v. California, a closely watched case that could decide the fate of the Affordable Care...
From the Journals
New study suggests milk could increase breast cancer risk
Drinking 1/4 to 1/3 cup of dairy milk per day was associated with a 30% increased risk of developing breast cancer.
Guidelines
New guideline offers recommendations for reproductive health in patients with rheumatic diseases
Among its many recommendations, the guideline strongly advises that women with RMD considering pregnancy switch to pregnancy‐compatible medication...
Latest News
In gestational diabetes, early postpartum glucose testing is a winner
GRAPEVINE, TEX. – Inpatient postpartum testing captured 99 of 100 patients without sacrificing accuracy.
News
U.S. reports first death from COVID-19, possible outbreak at long-term care facility
Health officials in Washington state said they are investigating a long-term care facility with two presumptive positive cases of COVID-19 and...
News from the FDA/CDC
CDC revises COVID-19 test kits, broadens ‘person under investigation’ definition
The geographic areas of concern were also expanded to reflect the week’s explosion of cases in Western Europe, Iran, and Asia.
From the Journals
Endocrine Society advises on use of romosozumab for osteoporosis
The update to the 2019 guideline specifies which postmenopausal women should, and should not, receive the drug.